Bioequivalence and Food Effect Assessment of 2 Fixed‐Dose Combination Formulations of Dolutegravir and Lamivudine

This single‐dose study evaluated the bioequivalence, food effect, and safety of 2 experimental, 2‐drug, fixed‐dose formulations of 50 mg dolutegravir and 300 mg lamivudine (formulation AH and formulation AK) as compared with coadministration of single‐entity tablets of 50 mg dolutegravir and 300 mg...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Pharmacol Drug Dev
Main Authors: Dumitrescu, Teodora Pene, Peddiraju, Kavita, Fu, Caifeng, Bakshi, Kalpana, Yu, Shui, Zhang, Zhiping, Tenorio, Allan R., Spancake, Chris, Joshi, Shashidhar, Wolstenholme, Allen, Adkison, Kimberly
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7028125/
https://ncbi.nlm.nih.gov/pubmed/31724343
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.740
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados